User:Stefan J. Borgwardt: Difference between revisions
imported>Larry Sanger m (Creating user page with biography of new user.) |
John Leach (talk | contribs) m (Text replacement - "ray matter" to "rey matter") |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{AccountNotLive}} | |||
Stefan J. Borgwardt (MD) graduated from the Charité Medical School, Humboldt-University of Berlin, in 2002 with a degree in medicine. He trained in psychiatric practice and research methodology at the University Hospital in Basel. | Stefan J. Borgwardt (MD) graduated from the Charité Medical School, Humboldt-University of Berlin, in 2002 with a degree in medicine. He trained in psychiatric practice and research methodology at the University Hospital in Basel. | ||
He was then granted a post-doctoral fellowship for young researchers by the Swiss National Science Foundation. In 2004 he became a clinical research worker in the Section of Neuroimaging, Division of Psychological Medicine, at the Institute of Psychiatry, King´s College London and worked with Professor Philip McGuire. | He was then granted a post-doctoral fellowship for young researchers by the Swiss National Science Foundation. In 2004 he became a clinical research worker in the Section of Neuroimaging, Division of Psychological Medicine, at the Institute of Psychiatry, King´s College London and worked with Professor Philip McGuire. | ||
He is currently working in the Early Detection of Psychosis Project (FEPSY) in Basel and also affiliated with the Institute of Psychiatry in London. His research interests include structural and functional neuroimaging, the prodrome and early phase of psychosis, neurocognitive and genetic mechanisms in schizophrenia, | He is currently working in the Early Detection of Psychosis Project (FEPSY) in Basel and also affiliated with the Institute of Psychiatry in London. His research interests include structural and functional neuroimaging, the prodrome and early phase of psychosis, neurocognitive and genetic mechanisms in schizophrenia, grey matter atrophy in Multiple Sclerosis, and the neurofunctional mechanisms of cannabinoids. Clinical interests include prodromal and early psychosis and neuropsychiatry. | ||
{{DEFAULTSORT:Borgwardt, Stefan J.}} | |||
[[Category:CZ Authors|Borgwardt, Stefan J.]] | [[Category:CZ Authors|Borgwardt, Stefan J.]] | ||
[[Category:Inactive CZ Editors|Borgwardt, Stefan J.]] | |||
[[Category:CZ Editors|Borgwardt, Stefan J.]][[Category:Health Sciences Authors|Borgwardt, Stefan J.]] [[Category:Health Sciences Editors|Borgwardt, Stefan J.]] [[Category:Psychology Authors|Borgwardt, Stefan J.]] [[Category:Psychology Editors|Borgwardt, Stefan J.]] | [[Category:Health Sciences Authors|Borgwardt, Stefan J.]] | ||
[[Category:Inactive Health Sciences Editors|Borgwardt, Stefan J.]] | |||
[[Category:Psychology Authors|Borgwardt, Stefan J.]] | |||
[[Category:Inactive Psychology Editors|Borgwardt, Stefan J.]] | |||
Latest revision as of 10:27, 1 April 2024
The account of this former contributor was not re-activated after the server upgrade of March 2022.
Stefan J. Borgwardt (MD) graduated from the Charité Medical School, Humboldt-University of Berlin, in 2002 with a degree in medicine. He trained in psychiatric practice and research methodology at the University Hospital in Basel.
He was then granted a post-doctoral fellowship for young researchers by the Swiss National Science Foundation. In 2004 he became a clinical research worker in the Section of Neuroimaging, Division of Psychological Medicine, at the Institute of Psychiatry, King´s College London and worked with Professor Philip McGuire.
He is currently working in the Early Detection of Psychosis Project (FEPSY) in Basel and also affiliated with the Institute of Psychiatry in London. His research interests include structural and functional neuroimaging, the prodrome and early phase of psychosis, neurocognitive and genetic mechanisms in schizophrenia, grey matter atrophy in Multiple Sclerosis, and the neurofunctional mechanisms of cannabinoids. Clinical interests include prodromal and early psychosis and neuropsychiatry.